0001562180-18-000334.txt : 20180117
0001562180-18-000334.hdr.sgml : 20180117
20180117170001
ACCESSION NUMBER: 0001562180-18-000334
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180117
FILED AS OF DATE: 20180117
DATE AS OF CHANGE: 20180117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VAN LUNSEN GIL J
CENTRAL INDEX KEY: 0001205014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16633
FILM NUMBER: 18532079
MAIL ADDRESS:
STREET 1: C/O HOGAN & HARTSON LLP
STREET 2: 1470 WALNUT STREET SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC
CENTRAL INDEX KEY: 0001100412
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841460811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 3033816600
MAIL ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2018-01-17
false
0001100412
ARRAY BIOPHARMA INC
ARRY
0001205014
VAN LUNSEN GIL J
C/O ARRAY BIOPHARMA INC.
3200 WALNUT STREET
BOULDER
CO
80301
true
false
false
false
Common Stock
2018-01-17
4
M
false
15000.00
1.74
A
34297.00
D
Common Stock
2018-01-17
4
M
false
6500.00
2.46
A
40797.00
D
Common Stock
2018-01-17
4
S
false
21500.00
12.94
D
19297.00
D
Stock Option (Right to Buy)
2.46
2018-01-17
4
M
false
6500.00
0.00
D
2012-10-26
2021-10-26
Common Stock
6500.00
13500.00
D
Stock Option (Right to Buy)
1.74
2018-01-17
4
M
false
15000.00
0.00
D
2019-10-29
Common Stock
15000.00
0.00
D
These trades were made pursuant to a Rule 10b5-1 trading plan.
Options vested in three equal annual installments commencing November 1, 2009 and ending November 1, 2011.
Jason Haddock, attorney in fact for Reporting Person
2018-01-17